Related Experiment Video
Updated: Jul 21, 2025

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
MicroRNA-765 is upregulated in myelodysplastic syndromes and induces apoptosis via PLP2 inhibition in leukemia cells
1Department of Laboratory Medicine, Chosun University College of Medicine, Gwangju, Korea.
Background:
Epigenetic studies, particularly research on microRNA (miRNA), have flourished. The abnormal expression of miRNA contributes to the development of hematologic malignancies. miR-765 has been reported to inhibit cell proliferation by downregulating proteolipid protein 2 (PLP2), which causes apoptosis. We investigated miR-765 dysregulation in myelodysplastic syndromes (MDS).
Methods:
We compared the expression profiles of miR-765 in 65 patients with MDS and 11 controls. Cell proliferation and apoptosis assays were performed to determine the in vitro effects of miR-765 on leukemia cells transfected with the miR-765 mimic. Reverse transcription quantitative PCR (RT-qPCR) and western blotting were performed to examine the targets of miR-765.
Results:
We found that miR-765 levels were upregulated 10.2-fold in patients with MDS compared to controls. In refractory cytopenia with multilineage dysplasia, the percentage of patients with elevated miR-765 levels was significantly higher than in other forms of MDS. Experiments with leukemia cells revealed that transfection with a miR-765 mimic inhibited cell proliferation and induced apoptosis. RT-qPCR and western blotting demonstrated that the target of miR-765 was PLP2.
Conclusion:
These findings imply that upregulation of miR-765 induces apoptosis via downregulation of PLP2 and may have a role in MDS pathogenesis.
Insights
MicroRNA-765 (miR-765) is upregulated in myelodysplastic syndromes (MDS). This upregulation inhibits leukemia cell proliferation and induces apoptosis by downregulating proteolipid protein 2 (PLP2), suggesting a role in MDS pathogenesis.
Area of Science:
- Hematology
- Molecular Biology
- Epigenetics
Background:
- MicroRNA (miRNA) dysregulation is implicated in hematologic malignancies.
- miR-765 has been shown to inhibit cell proliferation and induce apoptosis by targeting proteolipid protein 2 (PLP2).
- This study investigates the role of miR-765 in myelodysplastic syndromes (MDS).
Purpose of the Study:
- To investigate miR-765 dysregulation in myelodysplastic syndromes (MDS).
- To determine the functional role of miR-765 in leukemia cells.
- To identify the molecular targets of miR-765 in MDS.
Main Methods:
- Comparative analysis of miR-765 expression in 65 MDS patients and 11 controls using RT-qPCR.
- In vitro cell proliferation and apoptosis assays in leukemia cells transfected with miR-765 mimic.
- Validation of miR-765 targets (PLP2) using RT-qPCR and western blotting.
Main Results:
- miR-765 levels were significantly upregulated (10.2-fold) in MDS patients compared to controls.
- Elevated miR-765 was more prevalent in refractory cytopenia with multilineage dysplasia.
- miR-765 mimic transfection inhibited leukemia cell proliferation and induced apoptosis, with PLP2 identified as a direct target.
Conclusions:
- Upregulation of miR-765 in MDS induces apoptosis through PLP2 downregulation.
- miR-765 may play a significant role in the pathogenesis of myelodysplastic syndromes.
- These findings highlight miR-765 as a potential therapeutic target in MDS.
Related Concept Videos
MicroRNAs
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Induced Pluripotent Stem Cells
Somatic...

